Dr Omar El-Gaby

NHS

01691 404475

Anti Phospholipid Syndrome (APS)

MD, FRCP, DIM, MSc in Rheumatology

2014 - RJAH

• Rheumatology

GMC, RCP and BMA

Fibromyalgia syndrome (FMS), Axial Spondyloarthritis (Ax. SpA), and Connective Tissue Diseases (CTD)

Research Work 2022 -2023 1. BSRBR-RA: (British Society for Rheumatology Biologics Register for Rheumatoid Arthritis, BSRBR-RA) 2. (BSR-PsA) British Society for Rheumatology Psoriatic Arthritis Register 3. GLAD Genetic Links to Anxiety and Depression 4. RUDY Rare and Undiagnosed Diseases Study 5. IMID Immune-Mediated Inflammatory Diseases) BioResource, part of the National Institute for Health and Care Research BioResource 6. NCMH National centre for mental health "Trauma" 7. UK-IVAS United Kingdom and Ireland vasculitis susceptibility and patient outcomes study Previous Researches · 2014: Co-investigator, a multicenter, prospective, observational cohort study is to evaluate the real-world safety and effectiveness of ErelziTM, an etanercept biosimilar (COMPACT). · 2014: The COordiNated Care of Rare Diseases (CONCORD) study aims to explore how care for rare diseases is coordinated in the UK. · 2013: I am the co-investigator for TRACE RA a multi-centre MRC funded trial my study responsibilities are to obtain medical history, perform clinical examinations, assessment of inclusion/exclusion criteria and CRF Signature. · 2010 – 2011: “Sink or swim”: an evaluation of the clinical characteristics of individuals with high bone mass. I obtained medical history, performed clinical examinations, and assessed inclusion/exclusion criteria. · 2009 – 2010: ‘Are there evidence-based strategies in the treatment of Antiphospholipid Syndrome in pregnancy?' This was the dissertation part of the MSc in Rheumatology. It is a purely literature-based exercise. · 2008 – 2009 ‘What is the role of Th17 cell in Rheumatic diseases?' as a part of the MSc in Rheumatology course. Literature review · 2001 – 2002 International, multicentre, randomised, double-blind, double- dummy parallel group active controlled endoscopic study of gastrointestinal effects of CCOX189 with Rheumatoid Arthritis using Ibuprofen and Celecoxib as comparators – I obtained medical history, performed clinical examinations, and assessed inclusion/exclusion criteria. · 1996 – 1998 "Apolipoproteins and Lupus Anticoagulants study in Geriatrics." Thesis for partial fulfilment of MD, Faculty of Medicine, Ain-Shams University Hospital, Cairo, Egypt · 1997 – 1997 "Primary Antiphospholipid Syndrome” As part of the Diploma. It was about the new clinical picture and recent management at the Royal Postgraduate Medical School, Hammersmith Hospital, University of London - literature review.